Trending...
- Sober.Buzz the Sober Token : Ticker $BUZZ
- Art Imagined Photography to Be Showcased at Expo Metro Barcelona's The Art Tunnel
- Global Families Turn to Young Travelers Concierge Amid Rising Safety Concerns in the U.S
FAYETTEVILLE, Ark. - PennZone -- Lineus Medical announces that it has added a new executive team member with the hiring of Larry Hayes from Richmond, VA. Larry joins Lineus Medical as Vice President of Sales and leads all sales related efforts for the company.
Larry has over 20 years of experience across the medical device and medical technology field and has worked with 4 different successful early-stage startups. Before becoming Vice President of Sales at Lineus Medical, he was the Vice President Interventional Imaging at GE Healthcare where he led commercial teams in the United States and Canada for GE's Interventional Imaging Systems. He was the Vice President of International Sales, Marketing, and Commercial Strategy at IntroCare where he grew their global sales, and improved their marketing, commercial, regulatory, and medical affairs functions. Larry spent 8 years working abroad growing international sales and relations at EziSurg Medical and Vascular Flow Technologies. Prior to his international experience, Larry held several sales management positions at Banyan Biomarkers and W.L Gore & Associates. He earned a Bachelor of Arts in English at Catawba College.
More on The PennZone
The CEO of Lineus Medical, Vance Clement, stated "Larry has a vast experience with startup companies in motivating and leading sales teams. We have a great product and a good base of customers, and we are excited to work with Larry as we take sales to new heights."
"I'm very excited to join the talented team at Lineus Medical," said Larry Hayes. "The clinical results of the company's flagship product, SafeBreak Vascular, showed significant improvements over the current standard of care, with promising health-economic outcomes that benefit clinicians and their patients1. I'm looking forward to optimizing our commercial strategy and growing sales significantly."
SafeBreak Vascular is the only break-away device for IV lines proven to reduce IV complications.1 When a harmful force is placed on the line, SafeBreak intentionally separates to remove the damaging force and protect the patient's IV. When SafeBreak separates, valves on both ends of the device close preventing medicine spills from the pump and blood loss from the patient. To replace SafeBreak, each component is unthreaded from the line, a new sterile SafeBreak is installed, and the patent's infusion is restarted. Patients avoid additional needlesticks, nurses save time, and hospitals save money. 1 It's a win-win-win.
More on The PennZone
About Lineus Medical
Lineus Medical is the developer of a break-away technology that is proven to reduce IV restarts and IV complications.1 Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn.
1. Data on File
MKG 0269 Rev 00
Larry has over 20 years of experience across the medical device and medical technology field and has worked with 4 different successful early-stage startups. Before becoming Vice President of Sales at Lineus Medical, he was the Vice President Interventional Imaging at GE Healthcare where he led commercial teams in the United States and Canada for GE's Interventional Imaging Systems. He was the Vice President of International Sales, Marketing, and Commercial Strategy at IntroCare where he grew their global sales, and improved their marketing, commercial, regulatory, and medical affairs functions. Larry spent 8 years working abroad growing international sales and relations at EziSurg Medical and Vascular Flow Technologies. Prior to his international experience, Larry held several sales management positions at Banyan Biomarkers and W.L Gore & Associates. He earned a Bachelor of Arts in English at Catawba College.
More on The PennZone
- NBA Champion Lamar Odom Launches Anti-Addiction Meme Coin, Ushering in a Disruptive Innovation in Web3
- Aureli Construction Sets the Standard for Seamless Home Additions in Greater Boston
- Actuated Medical Launches Participating Preferred Series A Round, Led by Keiretsu Forum Mid-Atlantic, South-East, & Texas
- ScreenPoints Puts Film Investors in the Credits—and in the Money With New FinTech Platform
- Viatris Announces Positive Top-Line Results from Two Pivotal Phase 3 Studies of Novel Fast-Acting Meloxicam (MR-107A-02) for the Treatment of Moderate-to-Severe Acute Pain
The CEO of Lineus Medical, Vance Clement, stated "Larry has a vast experience with startup companies in motivating and leading sales teams. We have a great product and a good base of customers, and we are excited to work with Larry as we take sales to new heights."
"I'm very excited to join the talented team at Lineus Medical," said Larry Hayes. "The clinical results of the company's flagship product, SafeBreak Vascular, showed significant improvements over the current standard of care, with promising health-economic outcomes that benefit clinicians and their patients1. I'm looking forward to optimizing our commercial strategy and growing sales significantly."
SafeBreak Vascular is the only break-away device for IV lines proven to reduce IV complications.1 When a harmful force is placed on the line, SafeBreak intentionally separates to remove the damaging force and protect the patient's IV. When SafeBreak separates, valves on both ends of the device close preventing medicine spills from the pump and blood loss from the patient. To replace SafeBreak, each component is unthreaded from the line, a new sterile SafeBreak is installed, and the patent's infusion is restarted. Patients avoid additional needlesticks, nurses save time, and hospitals save money. 1 It's a win-win-win.
More on The PennZone
- Pathways to Adulthood Conference May 17 at Melville Marriott Honoring NYS Assembly Member Jodi Giglio, Suffolk County Legislator Nick Caracappa
- Adster Techologies awarded US Patent for breakthrough innovation in reducing latency in Ad Serving
- Robert Fabbio Inducted into the Austin Technology Council Hall of Fame
- Cybersecurity is Protecting Your Personal Information and Your Portfolio
- L2 Aviation Celebrates Grand Opening of New Facility at Cincinnati/Northern Kentucky International Airport (CVG)
About Lineus Medical
Lineus Medical is the developer of a break-away technology that is proven to reduce IV restarts and IV complications.1 Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn.
1. Data on File
MKG 0269 Rev 00
Source: Lineus Medical
Filed Under: Health, Technology
0 Comments
Latest on The PennZone
- ImagineX, in Collaboration with Qualys, Launches New mROC Services to Transform Enterprise Cyber Risk Management
- Ditch Micromanagement: New Leadership Book for Results-Driven, Accountability-Based Teams
- Jay Tapp was named Managing Director in British Columbia
- Children's Hospital of Philadelphia Researchers Recommend New Standard of Care for Families with Hereditary Neuroblastoma Linked to ALK Mutation
- GormanSquared Announces Provisional Patent
- Hubei Heavy Equipment Makes a Striking Appearance at CIMT and Competes with International Brands
- 20 Patents Issued Worldwide, Cementing Company Leadership. First Ever Cable-Free 12-Lead ECG: HeartBeam, Inc. (Stock Symbol: BEAT)
- NASDAQ Uplisting for Higher Market Exposure and Wide Corporate Benefits to AI Boosted Marketing Company On Track Towards $1 Billion Revenue by 2027
- Congressional Men's Health Caucus Shows Bipartisan Consensus and Focus on Prevention, Mental Health, and Closing the Lifespan Gap
- Chewy Chums™ Launches NeverBite™ on Kickstarter
- DuoKey, Axiomtek and Blue Edge Network Partner to Enhance Smart Cities with Privacy-Preserving Urban Safeguarding and Fleet Management
- Fangzhou Launches Otsuka's Third-Generation Leukemia Drug Ponatinib on its Platform
- Viatris Announces Appointments of Frank D'Amelio and Michael Severino, M.D., to the Company's Board of Directors
- Austin Keen Joins WakeFX RopePal as Official Brand Ambassador
- Bonelli Systems Expands Managed IT Services Nationwide, Leveraging Microsoft Azure Expertise
- $4.3 Million Patent Application Waiver Fee Granted by FDA on New Drug Application Fee for Treatment Addressing Suicidal Depression & PTSD: NRX Pharma
- Whistleblower Claims Dental Patient Deaths Likely Due to Book Ban
- xREnergy up as much as +3,094,634% on first day listed on the XRP Ledger. Ticker : $XRE
- Psychiatry's Legacy of Racism and Coercion Highlighted in Restraint Deaths
- New Book 'Cybersecurity Leadership' Guides SME Leaders to Make Smart, Strategic Security Decisions